ストックスクリーナーアプリを入手
37.51
11.60%
-4.92
プレマーケット:
37.08
-0.43
-1.15%
前日終値:
$42.43
開ける：
$39.16
24時間の取引高:
7.18M
Relative Volume:
3.06
時価総額：
$5.70B
収益：
$3.44B
当期純損益:
$75.20M
株価収益率:
71.60
EPS:
0.5239
ネットキャッシュフロー:
$49.30M
1週間 パフォーマンス:
-8.60%
1か月 パフォーマンス:
-29.77%
6か月 パフォーマンス:
+15.91%
1年 パフォーマンス:
-27.38%
1日の値動き範囲:
$35.62
$40.48
1週間の範囲:
$35.62
$42.58
52週間の値動き範囲:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
37.51 | 6.45B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 開始されました | Goldman | Sell |
| 2025-11-20 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet News
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... - Yahoo Finance
Bruker (NASDAQ:BRKR) Announces Earnings Results - MarketBeat
Why Bruker (BRKR) Stock Is Trading Lower Today - Finviz
Bruker Q4 2025 slides reveal organic decline, stock drops 14% despite FY 2026 optimism - Investing.com
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% - Investing.com
Bruker: Q4 Financial Results Overview - Bitget
Bruker (BRKR) Q4 Earnings Miss Estimates - Yahoo Finance
Bruker: Q4 Earnings Snapshot - kare11.com
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates - Yahoo Finance
Bruker earnings missed by $0.06, revenue topped estimates - Investing.com
Bruker Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Bruker Earnings Review: Q4 Summary - Benzinga
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
Bruker earnings up next: Can momentum continue after Q3 beat? - Investing.com
A Glimpse of Bruker's Earnings Potential - Benzinga
Candriam S.C.A. Cuts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation Announces the Launch of iNTApharma - marketscreener.com
Bruker (BRKR) Launches iNTApharma for Advanced Bioparticle Analy - GuruFocus
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - ChartMill
Bruker Announces Quarterly Preferred Stock Dividend - 富途牛牛
Old West Investment Management LLC Buys 338,618 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker to pay $3.9844 per share to preferred holders Mar. 2 - Stock Titan
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Finviz
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast - marketscreener.com
Investors get Feb. 12 date for Bruker Q4 2025 earnings call - Stock Titan
Bruker (BRKR) to Release Quarterly Earnings on Thursday - MarketBeat
New York State Common Retirement Fund Has $12.05 Million Stake in Bruker Corporation $BRKR - MarketBeat
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛
Guggenheim Raises Price Target for Bruker Corporation (BRKR) - Finviz
Will Bruker Corporation outperform its industry peersGDP Growth & Proven Capital Preservation Tips - Mfd.ru
Levels Update: Will Bruker Corporation stock recover after earningsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Eclipse Bioinnovations, Inc. acquired Terrain Biosciences, Inc. from Magnetic Ventures and Bruker Corporation. - marketscreener.com
Bruker Corp (BRKR) Shares Down 2.98% on Jan 26 - GuruFocus
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $58 - 富途牛牛
Stocks To Watch: Bruker Sees Relative Strength Rating Rise To 82 - Investor's Business Daily
Bruker Corporation (BRKR): A Bull Case Theory - Finviz
TOFWERK joins Bruker: From partnership to full ownership - MSN
Revenues Working Against Bruker Corporation's (NASDAQ:BRKR) Share Price - 富途资讯
SG Americas Securities LLC Has $1.37 Million Stake in Bruker Corporation $BRKR - MarketBeat
Assessing Bruker (BRKR) Valuation After Recent Share Price Rebound And Conflicting Fair Value Signals - Yahoo Finance
Bruker (NASDAQ:BRKR) VP Sells $98,400.00 in Stock - MarketBeat
Citigroup Boosts Bruker (BRKR) Price Target, Maintains Neutral R - GuruFocus
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $53 - 富途资讯
September 18th Options Now Available For Bruker (BRKR) - Nasdaq
Mark Munch Sells 7,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (NASDAQ:BRKR) Stock Price Down 5.8%Should You Sell? - MarketBeat
Why Bruker (BRKR) Shares Are Plunging Today - Finviz
Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday? - Benzinga
Bruker Corp (BRKR) Shares Down 6.48% on Jan 13 - GuruFocus
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.31%
大文字化:
|
ボリューム (24 時間):